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Short-rib polydactyly syndromes (SRPS I–V) are a group of lethal congenital disorders characterized by shortening of the ribs and long
bones, polydactyly, and a range of extraskeletal phenotypes. A number of other disorders in this grouping, including Jeune and Ellis-van
Creveld syndromes, have an overlapping but generally milder phenotype. Collectively, these short-rib dysplasias (with or without poly-
dactyly) share a common underlying defect in primary cilium function and form a subset of the ciliopathy disease spectrum. By using
whole-exome capture andmassive parallel sequencing of DNA from an affected Australian individual with SRPS type III, we detected two
novel heterozygous mutations inWDR60, a relatively uncharacterized gene. These mutations segregated appropriately in the unaffected
parents and another affected family member, confirming compound heterozygosity, and both were predicted to have a damaging effect
on the protein. Analysis of an additional 54 skeletal ciliopathy exomes identified compound heterozygous mutations in WDR60 in a
Spanish individual with Jeune syndrome of relatively mild presentation. Of note, these two families share one novel WDR60missense
mutation, although haplotype analysis suggested no shared ancestry. We further show that WDR60 localizes at the base of the primary
cilium in wild-type human chondrocytes, and analysis of fibroblasts from affected individuals revealed a defect in ciliogenesis and aber-
rant accumulation of the GLI2 transcription factor at the centrosome or basal body in the absence of an obvious axoneme. These find-
ings show that WDR60 mutations can cause skeletal ciliopathies and suggest a role for WDR60 in ciliogenesis.Ciliopathies form an expanding class of heterogeneous
congenital diseases mechanistically linked by an underly-
ing dysfunction of the primary cilium (reviewed in Waters
and Beales,1 Hildebrandt et al.,2 and Lee and Gleeson3).
This microtubule-based cellular extension is present on
virtually all vertebrate cell types during quiescence and
has been linked to a number of pivotal developmental sig-
naling pathways, most notably the hedgehog cascade.4
The cellular anchor of the cilium is the basal body, which
derives from the mother centriole and nucleates the
axonemal extension.
Ciliopathies are variably characterized by anomalies
affecting most major organs and encompass diseases
such as polycystic kidney disease and Bardet-Biedl, Joubert,
and Meckel syndromes. Within the ciliopathies, a sub-
group of disorders including short-rib polydactyly syn-
drome (SPRS), Jeune syndrome or asphyxiating thoracic
dystrophy (JATD [MIM 208500]), Ellis-van Creveld
syndrome (EVC [MIM 225500]), and Sensenbrenner
syndrome or cranioectodermal dysplasia (CED [MIM
218330]) are characterized by skeletal abnormalities
including a small rib cage, shortening of the long bones,
and in some cases, polydactyly.5–7 The severe SRPS class
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The American(Saldino-Noonan syndrome [MIM 263530]), type II
(Majewski syndrome [MIM 263520]), type III (Verma-
Naumoff syndrome [MIM 263510]), type IV (Beemer-
Langer syndrome [MIM 269860]), and the recently
recognized type V (MIM 614091).8 Among the skeletal cil-
iopathies, the SRPS subtypes are the most severe and are
incompatible with postnatal life. Skeletal ciliopathies
may also manifest extraskeletal phenotypes including
polycystic kidney disease, retinal degeneration, and car-
diac, liver, and brain anomalies.
To date many mutations causing skeletal ciliopathies
affect genes encoding components of the intraflagellar
transport (IFT) machinery, a motor-driven trafficking pro-
cess responsible for transporting proteins required for cilia
assembly and function along the axoneme.9 Transport in
the anterograde direction, toward the cilia tip, is mediated
by the kinesin-2 motor and a complex of proteins known
as IFT-B; opposing retrograde trafficking relies on the
dynein-2 motor and the IFT-A complex, although recent
evidence suggests that IFT-A proteins are also involved in
regulating anterograde trafficking.10 With the exception
of IFT80 (MIM 611177) mutations in Jeune syndrome11
and SRPS type III,12 most skeletal ciliopathies are caused
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Figure 1. Clinical Features of Individuals
from the SRP and Jeune Syndrome
Families
(A and B) X-rays of individuals (A)
SKDP42.3 (II-1 in Figure 2A) and (B)
SKDP42.4 (II-2 in Figure 2A), showing
shortening of the ribs and long bones
and bowing of the limbs.
(C–F) Individual JATD76 (II-1 in Figure 2A)
displays typical hallmarks of Jeune syn-
drome: mildly narrowed thorax (C), also
shown in (E); polydactyly (D, arrow points
to remnants of an extra digit subsequently
removed from the right hand); handlebar
clavicles (E, asterisks); and acetabular spurs
(F, arrows).retrograde IFT motor protein DYNC2H1.8,13–21 Non-IFT
genes implicated in skeletal ciliopathies include NEK1
(MIM 604588) in SRPS type II22 and EVC1 (MIM 604831)
and EVC2 (MIM 607261) in EVC.23
Recent advances in massive parallel sequencing technol-
ogies offer the opportunity to identify disease-causing
mutations for Mendelian disorders in small families previ-
ously refractory to classical linkage mapping approaches.
With many ciliopathy cases still unresolved at the molecu-
lar level and more than 1,000 proteins in the ciliary prote-
ome, this approach is likely to extend the repertoire of
genes mutated in ciliopathies. Here we report the use of
exome capture and massive parallel sequencing to identify
mutations in WDR60, a relatively uncharacterized gene,
in two separate families with SRPS and Jeune syndrome,
respectively.
The first family is a nonconsanguineous Australian fam-
ily of predominantly British but also Maori descent, with
healthy parents and two affected individuals with SRPS
type III (Figures 1A and 1B). Individual SKDP42.3 (II-1 in
Figure 2A) presented with short long bones on ultrasound
at 16 weeks’ gestation. Follow-up ultrasound at 31 weeks
demonstrated polyhydramnios, severe shortening of long
bones with bowed femurs, macrocephaly, short ribs, and
ambiguous genitalia. The baby was born at 32 weeks’ gesta-
tion but died at 2 hr of age. Autopsy confirmed the above
findings, and in addition revealed postaxial polydactyly
of both hands, syndactyly of some fingers and toes, acetub-
ular spurs, pancreatic fibrosis, mild dilatation of renal
tubules, and enlarged liver with ductal platemalformation.516 The American Journal of Human Genetics 93, 515–523, September 5, 2013The second affected individual from
this family (SKDP42.4; II-2 in Fig-
ure 2A) had an unremarkable ultra-
sound scan at 13 weeks’ gestation
but demonstrated short ribs and short
bowed limbs on ultrasound scan at
17 weeks’ gestation. The pregnancy
was terminated at this stage. Autopsy
further revealed brachydactyly (not
polydactyly), conical epiphyses, hy-
poplastic trabecular, depressed nasalbridge, ventricular septal defect (VSD), focal cystic changes
in the kidneys, prominent bile duct plates, and early evi-
dence of pulmonary hypoplasia. Parents did not consent
to autopsy of the brain.
With University of Queensland ethics approval
(#2011000876) and informed consent, whole-exome
sequencing was performed on genomic DNA from individ-
ual SKDP42.3 (II-1 in Figure 2A). Sequencing libraries were
constructed with the Illumina TruSeqDNA sample prepara-
tion kit, combined in pools of six for target capture by the
Illumina TruSeq Exome Enrichment Kit, and assessed pre-
and postcapture for quality and yield with the Agilent
High Sensitivity DNA assay and KAPA Library Quantifica-
tion Kit. Massive parallel sequencing was performed with
six samples per flow cell lane via the Illumina HiSeq2000
platform and version 2 SBS reagents to generate 100 bp
paired-end reads. After demultiplexing, the Illumina Data
Analysis Pipeline software (CASAVA v.1.8.2) was used for
initial base calling. Sequence data were aligned to the
current build of the human genome (UCSC Genome
Browser, hg19, released February 2009) via the Novoalign
alignment tool (v.2.08.02 1);24 sequence alignment files
were converted by SAMtools (v.0.1.14)25 and Picard tools
(v.1.42) (see Table S1 available online for mapping,
coverage, and base calling statistics). SNPs and indels
were called with the Genome Analysis Toolkit (GATK
v.5506)26,27 and annotated by ANNOVAR.28
Further analysis of sequence data was performed with
custom scripts employing R and Bioconductor. We re-
tained good-quality SNPs and indels (minimum depth of
Figure 2. Segregation of WDR60 Variants and the Predicted Effect on Protein
(A) Pedigree structure andWDR60 genotypes for the Australian SRPS family (SKDP42: individual II-1 ¼ SKDP42.3; II-2 ¼ SKDP42.4) and
the Spanish Jeune syndrome family (JATD76). Sequencing chromatograms of genomic DNA show examples of each of the WDR60
mutations. Asterisks mark mutated base; dotted line in JATD76 sequence marks the intron 13/exon 14 junction.
(B) Agarose gel showing RT-PCR products amplified from the proband in family JATD76 (II-1) and control cDNA, using primers in exon
13 and 18, spanning the splice mutation predicted to result in skipping of exon 14 (see Figure S1 for schema). Abbreviations are as
follows: M, marker; C, control.
(C) Sequencing chromatogram of the JATD76 (II-1) cDNA sample showing the nondeleted (upper line) and exon-14-skipped (lower line)
alleles. Arrow indicates exon 15 boundary with exon 14 (control allele) or 13 (mutated allele). Note the sequencing shown is in the
reverse orientation. Primer sequences available on request.
(D) Schematic of human WDR60 showing the main protein domains and the positions of the residues affected by the three muta-
tions found in this study. The residue altered by the c.2246C>T (p.Thr749Met) missense mutation present in both families is con-
served back to Drosophila. (Human ENST00000407559; Mouse ENSMUSG00000042050; Chicken ENSGALG00000006558; Zebrafish
ENSDART00000109166; C. elegans c27F2.1; Drosophila FBgn0034095.)
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coverage for SNP calling: >10-fold for homozygous SNPs,
>15-fold for heterozygous SNPs). Additionally, we used
variants that passed GATK Variant Quality Score Recalibra-
tion. Remaining SNPs and indels were assessed according
to prediction of potentially damaging consequence (‘‘non-
synonymous SNV,’’ ‘‘splicing,’’ ‘‘frameshift substitution,’’
‘‘stopgain SNV,’’ ‘‘stoploss SNV’’) by using both RefSeq
and UCSC transcripts. Further filtering excluded SNPs
with a minor allele frequency (MAF) > 0.001 observed in
NCBI dbSNP (release 135), 1000 Genomes,29 1000
Genomes small indels (called with the DINDEL pro-
gram30), the SNPs of 46Genomes release by Complete
Genomics, and other whole exomes from more than
1,200 control samples run internally by similar capture
technology. Variants not present in any of these databases
were considered novel.
Given that SRPS is known to follow a recessive mode of
inheritance, compound heterozygosity was considered
most likely in this nonconsanguineous family. We there-
fore analyzed the data for heterozygous carriage of at least
two rare (either novel or MAF < 0.001) nonsynonymous
SNPs or indels in the same gene, both carried by the
affected individual. After quality-filtering as described,
two genes remained with compound heterozygosity for
either novel or rare SNPs: WDR60 and CILP (MIM
603489). The data were also analyzed for homozygosity
of novel or rare SNPs (MAF < 0.001); no genes were identi-
fied by this analysis (see Table S2 available online for sum-
mary of identified variants).
The compound heterozygousWDR60 variants identified
in individual SKDP42.3 (II-1 in Figure 2A) are both novel.
One, in exon 15 (c.1891C>T [p.Gln631*]; RefSeq accession
number NM_018051.4), introduces a stop codon in a
highly conserved region (GERP [Genomic Evolutionary
Rate Profiling]31 score 4.15). The other, in exon 17
(c.2246C>T [p.Thr749Met]), is a nonsynonymous variant
also found in a highly conserved region (GERP score
5.04). The function prediction algorithms PolyPhen,32
MutationTaster, and SIFT33 predicted the nonsynonymous
variant to be ‘‘probably damaging’’ (0.999), ‘‘disease-
causing,’’ and ‘‘deleterious,’’ respectively. Sanger se-
quencing demonstrated appropriate segregation of these
mutations in the parents and other affected individual in
this family (Figure 2A). Although rare (MAF < 0.0005)
compound heterozygous mutations were also found in
CILP, neither were novel, both were predicted to be
benign and tolerated by PolyPhen and SIFT, and Sanger
sequencing showed that they did not segregate appropri-
ately in the family and thus could not be causative.
Thus, mutations in WDR60 were considered the most
likely cause of disease in the Australian family. In support
of this we reviewed the exome sequencing data of
WDR60 from 1,985 unrelated individuals. A total of 152
SNPs and indels were identified, 87 of which had MAF <
0.005; of these 28 were in coding regions (including splice
sites), and 25 passed quality control. No individual was a
compound heterozygote for mutations in WDR60, sug-518 The American Journal of Human Genetics 93, 515–523, Septembgesting that the probability of finding compound hetero-
zygous WDR60 mutations randomly in the human
population is low. However, to further support causality
of these mutations, we interrogated exome sequencing
data from an additional 54 individuals with skeletal
ciliopathies, primarily Jeune syndrome. All samples were
obtained with approval of the relevant ethical and
licensing authorities; in the United Kingdom, this was
the UCL-ICH/Great Ormond St. Hospital Research Ethics
Committee (#08/H0713/82).
For these exomes, library preparation, sequencing, align-
ment, and calling was performed largely as per the Austra-
lian family, with details as previously described.20 Exome
variant profiles were filtered by EVAR software tool v.0.2.2
beta. After filtering against 75 control exomes from the
UK10K project, remaining variants were filtered for
MAF < 0.005 in dbSNP (release 137), 1000 Genomes, and
the NHLBI Exome Sequencing Project, then filtered by a
quality score implicating a base error rate <0.1%. Intronic
variants within 12 bp of an intron/exon boundary and
coding nonsynonymous variants (missense, nonsense,
and frameshifts) were retained. Finally, any genes with bial-
lelic variants with MAF > 0.005 in 500 control exomes
available via theUK10K project were removed, and remain-
ing candidate genes were checked for their presence in
the cilia proteome as a means of prioritization (see Table
S3 for summary of filtering steps and identified variants).
After filtering according to these criteria, one of the 54 in-
dividuals (JATD76, II-1 in Figure 2A) was found to carry two
potentially damaging heterozygous mutations in WDR60.
One of these is the same novel missense change carried
by the Australian family (c.2246C>T [p.Thr749Met]). The
other is a novel point mutation in intron 13 within the
conserved exon 14 splice acceptor site and was therefore
predicted to affect splicing of exon 14 (g.158706921T>A
[c.17033T>A]). This was confirmed by qRT-PCR and
sequencing of cDNA prepared from a fibroblast cell line
derived from individual JATD76 (II-1) (Figures 2B, 2C, and
S1). This showed that exon 14 was removed by aberrant
splicing, resulting in a frameshift, leading to premature
termination of the resultant protein (p.Ser569Aspfs*13).
BothWDR60mutations were shown by Sanger sequencing
to segregate appropriately in this family (Figure 2A).
Individual JATD76 (II-1) also carried compound hetero-
zygous variants in TTN (MIM 188840) and a homozygous
change in LAMA5 (MIM 601033). With respect to LAMA5,
a homozygous model of inheritance for an extremely rare
SNP was considered unlikely in the absence of a history of
consanguinity in this family; further, the observed variant
(c.6982G>A [p.Ala2328Thr]; RefSeq NM_005560.3) was
predicted to affect a nonconserved residue (GERP score
0.34) and is likely to be ‘‘benign,’’ ‘‘a polymorphism,’’ or
‘‘tolerated’’ according to PolyPhen2, MutationTaster, and
SIFT. Finally, although Lama5 mutant mice do display
polycystic kidney disease and neural tube closure defects,
they show no reported signs of the skeletal defects that
characterize Jeune syndrome.34 Although the variants iner 5, 2013
TTN affected highly conserved amino acids (GERP scores
>4), PolyPhen2, MutationTaster, and SIFT differed as
to their predicted effect. Although one (c.6950G>A
[p.Arg2317His]; RefSeq NM_133378.4) was predicted to
be ‘‘probably damaging,’’ ‘‘disease-causing,’’ and ‘‘delete-
rious’’ by these programs, respectively, the other
(c.7611A>T [p.Arg2537Ser]) was predicted to be a
benign polymorphism by Polyphen2 and MutationTaster,
although SIFT predicted deleterious effects. However, TTN
was excluded because exome sequencing commonly re-
veals mutations in this gene, probably because of its large
size (M.S., A.M.M.-L., E.L.D.; unpublished observation).
Furthermore, variants in TTN cause myopathy in humans
(MIM 608807, MIM 611705, MIM 603689), inconsistent
with the Jeune syndrome phenotype in this individual.
The affected individual JATD76 (II-1) is the first child of
healthy nonconsanguineous Spanish parents. Prenatal
ultrasound at 20–21 weeks’ gestation detected short
femora. Delivery was uneventful at 41 weeks’ gestation
(birth weight 3,170 g, 25th–50th centile; length at birth
49 cm, 50th centile; and head circumference at birth
36 cm, 75th–90th centile). At birth he presented with a nar-
row chest, preaxial polydactyly on the right hand (extra
digit subsequently removed by surgery), and a small clini-
cally insignificant ventricular septal defect (Figures 1C–1F).
At age 1 year he showed signs of failure to thrive (weight
6,640 g, <3rd centile; length 69 cm, 3rd centile), and at
age 5 years and 3 months remained on the lower extreme
of the growth charts (weight 14.5 kg, 5th centile; height
101 cm, 1st centile). He has no evidence of renal, hepatic,
retinal, neurological, or developmental problems to date
(now aged 5 years). Compared to the Australian SRPS
family, this represents a relatively mild clinical course.
Because both families in this study share one
missense mutation (c.2246C>T [p.Thr749Met]), and given
Australia’s recent migrant history, we investigated whether
this variant could represent a founder effect. The genotype
likelihoods for the variants were used to phase the data
via the software BEAGLE 3.3.2; subsequent association
analysis was performed with the BEAGLE Utilities program
Cluster2haps, which identifies haplotype clusters by
testing the allele sequences for association with the trait
status; results are reported as p values. TheWDR60 gene re-
gion for the cohort and control samples was also analyzed
with the R package hapFabia, which identifies short
identity-by-descent (IBD) segments in large sequencing
data. No significant shared haplotypes were identified by
either approach, excluding a common founder effect in
these two families (data not shown).
Sanger sequencing analysis for the three identified
WDR60 mutations in 55 additional Jeune syndrome sam-
ples with insufficient DNA for whole-exome sequencing
did not reveal any further cases. Because of the length of
WDR60, we have not sequenced the remaining exons of
WDR60 in these individuals.
WDR60 is a relatively uncharacterized evolutionarily
conserved protein predicted to contain four WD40 repeatThe Americandomains and two coiled-coil domains. These domains
have been implicated in protein-protein interactions, and
WD40 repeats in particular are highly represented in pro-
teins involved in IFT and cilia function.9 The c.1891C>T
mutation in family SKDP42 and the c.17033T>A muta-
tion in family JATD76 are both predicted to lead to trunca-
tion of the protein after the coiled-coiled domains but prior
to the WD40 repeats (p.Gln631* and p.Ser569Aspfs*13,
respectively); the c.2246C>T missense mutation in both
families is predicted to lead to an amino acid substitution
within the run of WD40 repeat sequences (p.Thr749Met;
Figure 2D). In addition, the relative intensity of the
mutant JATD76 splice allele versus wild-type allele by RT-
PCR analysis (Figure 2B) suggests that this mutant allele
is subject to some level of nonsense-mediated decay. In
short, all mutations are likely to result in loss or alteration
to the WD40 functional domains or loss of protein.
As is the case in general for ciliopathies,35 different mu-
tations in the same gene can lead to distinct skeletal cilio-
pathies with, for example, DYNC2H1 mutations found in
both Jeune syndrome and SRPS type III.16 Furthermore,
we have previously described significant phenotypic vari-
ability among Jeune syndrome individuals with DYNC2H1
mutations, including between siblings of identical
DYNC2H1 genotype.21 Consistent with this, there is a
marked difference in phenotypic severity between individ-
uals in the families in this study. Both families share a com-
mon missense mutation, and the other mutation in both
cases is predicted to introduce a premature stop codon.
These protein-truncating alleles may result in nonsense-
mediated mRNA decay or encode a nonfunctional trun-
cated protein, although production of a protein fragment
with some function cannot be ruled out. It is therefore
possible that differences in phenotypic severity may not
result fromWDR60 genotype alone, but rather may reflect
the effect of genetic modifying alleles, a phenomenon that
has also been well documented for ciliopathies,35 and/or
epigenetic, environmental, or stochastic effects.
Although WDR60 is relatively uncharacterized, two
recent proteomic analyses of cilia in mouse inner medul-
lary collecting duct (IMCD3) cells36 and in multiciliated
mouse tracheal epithelial cells37 identified this protein,
suggesting that it may have a function in the core processes
of ciliogenesis relevant to both primary and motile cilia. In
addition, functional genomics analyses of cilia inC. elegans
identified the WDR60 ortholog C27F2.1, and this protein
appears in the online ciliome, strongly suggesting a con-
served function for WDR60 at the cilium.38 In support of
this, one of these studies showed localization of exoge-
nously expressed WDR60 at the cilium in IMCD3 cells.36
We have now shown by using a commercially available
antibody that endogenous WDR60 localizes in a diffuse
pattern at the base of theprimary cilium in cultured immor-
talized C-28/I2 human chondrocytes (Figures 3A–3E).
We next analyzed primary fibroblasts derived from the
three individuals with WDR60 mutations to determine
the proportion of ciliated cells in cultures induced toJournal of Human Genetics 93, 515–523, September 5, 2013 519
Figure 3. WDR60 Localizes to the Base
of the Cilium in Human Chondrocytes
and Ciliogenesis Is Impaired in Fibroblast
Cultures from Affected Individuals
(A–E) C-28/I2 immortalized human chon-
drocytes were serum starved for 24 hr
in DMEMþ0.2% FBS prior to fixing in
4% paraformaldehyde (PFA). Cells were
stained with antibodies to acetylated
a-tubulin (green) and WDR60 (red),
showing localization of WDR60 at the
base of the cilium (marked with arrow-
heads in A and B; see Table S4 for details
of antibodies used). Nuclei were stained
with 40,6-Diamidino-2-Phenylindole
(DAPI; blue). Cells were imaged on an
Olympus Deltavision IX71 invertedmicro-
scope with a 1003 objective. High-power
images of boxed regions in (C) shown in
(D) and (E). Scale bars represent 10 mm in
(A)–(C) and 5 mm in (D) and (E).
(F–H) Graphs showing a decreased per-
centage of ciliated cells in fibroblasts pre-
pared from affected individuals SKDP42.3
(F), SKDP42.4 (G), and JATD76 (II-1; H)
versus control fibroblast lines from post-
natal foreskin (F, G) or adult skin (H). Cells
were cultured for a maximum of six pas-
sages and serum starved and fixed as
above. Acetylated a-tubulin-stained cilia
were counted manually and expressed as
a percentage of the number of nuclei.
Data shown are from a minimum of
three independent experiments. For each
experiment at least 100 cells were
counted, the mean percentage of ciliated cells was calculated, and the mean values compared statistically by a Student’s t test (***p <
0.0001) with Prism 5 (Graphpad) software. Error bars represent standard error of the mean (SEM).produce cilia by serum starvation (see legend to Figure 3 for
experimental details). Controls were fibroblasts from post-
natal foreskin (PromoCell, for SKDP42 analysis) or adult
skin (ECACC, for JATD76 analysis). These are optimal con-
trols for individuals SKDP42.3 (died at 2 hr postnatally)
and JATD76 (II-1; fibroblasts collected at age 5 years). The
postnatal control line was considered closest to the fetal
fibroblasts collected from SKDP42.4. Regardless, both con-
trol cultures (as well as an additional postnatal control
we analyzed) showed a comparable cilia/nuclei ratio of
approximately 70%, suggesting that the ability of fibro-
blasts to form cilia is not dependent on the age of collec-
tion. The percentage of ciliated cells was drastically
reduced in SKDP42.3 cells (Figure 3F). Likewise, a signifi-
cant, although less marked, reduction in the percentage
of ciliated cells was also observed in the SKDP42.4 and
JATD76 cultures (Figures 3G and 3H). In the minor per-
centage of mutant cells with a detectable cilium, there
was no obvious difference in length compared to control
cells. However, to check that stunted cilia were not masked
by the cytoplasmic microtubule network detected by acet-
ylated a-tubulin, used tomark the axoneme in these exper-
iments, we further quantified ciliated cells in SKDP42.3
cultures after staining of the axoneme with the Arf-like
small GTPase ARL13b. This confirmed reduced frequency
of readily detectable cilia, consistent with the acetylated520 The American Journal of Human Genetics 93, 515–523, Septemba-tubulin data (Figure S2). Taken together, these data sug-
gest a defect in ciliogenesis in these individuals and poten-
tially link WDR60 to this process.
Because skeletal ciliopathies have been linked primarily
to mutations in IFT genes, we next analyzed localization
of key IFT proteins by immunofluorescence analysis in
serum-starved SKDP42.3 cells. In control fibroblasts, the
IFT-A protein IFT144 and the IFT-B protein IFT88 are local-
ized at the transition zone, which lies between the basal
body and axoneme, and less prominently along the
axoneme (Figures 4A and 4D). In the small percentage of
SKDP42.3 ciliated cells, the normal distribution of both
of these proteins was essentially maintained (Figures 4C
and 4F). However, in those mutant cells that appear to
lack a primary cilium, both IFT144 (Figure 4B) and IFT88
(Figure 4E) accumulated at the centrosome or basal body
(as marked by g-tubulin).
These data are consistent with findings in MEFs derived
from mouse mutants that lack cilia because of defects in
anterograde IFT, including Kif3a and Ift172 mutant mice,
suggesting that IFT proteins, which are required for
axonemal extension, can be recruited to the basal body
even under conditions where cilium assembly is in-
hibited.39 IFT88 in particular has previously been reported
to be a centrosomal protein,40 so we next sought to charac-
terize localization of a noncentrosomal protein. For this weer 5, 2013
Figure 4. Localization of IFT and Trafficking Proteins in WDR60
Mutant Fibroblasts
Fibroblasts from individual SKDP42.3 and control fibroblast lines
were serum starved as described (see legend to Figure 3), fixed,
and stained for (A–C) IFT144 (red), (D–F; J–L) IFT88 (red), (G–I)
GLI2 (red), and (J–L) ARL13b (green). In (A)–(I), cells were cos-
tained for acetylated a-tubulin and g-tubulin (green). Nuclei
were stained with DAPI (blue), indicating that in (A) two indepen-
dent cells are shown. Localization in cells in the mutant cultures
that don’t form a detectable primary cilium are shown in (B),
(E), (H), and (K). Arrows point to accumulated proteins. In those
mutant cells that form a cilium, all proteins analyzed show a
similar localization to control cells as shown in (C), (F), (I), and
(L). For IFT144 experiments (A–C) only, cells were treated with
saponin (0.05% in PBS) for 1 min prior to fixation in 4% PFA for
10 min. In (D)–(I), cells were fixed in ice-cold MeOH for 5 min,
in (J)–(L) in 4% PFA. Cells were imaged on anOlympus Deltavision
IX71 inverted microscope with a 1003 objective. Scale bars repre-
sent 5 mm. See Table S4 for details of antibodies used.usedGLI2, which is a transcriptionalmediator of hedgehog
signaling and shuttles in and out of the cilium in response
to stimulation of the hedgehog pathway.41 Under basal
conditions in ciliated cells, GLI2 normally localizes
primarily to the tip of the cilium (Figure 4G), with further
enrichment at this localization upon treatment of hedge-
hog-responsive cells with the hedgehog agonist SAG.10
Those SKDP42.3 cells that possessed a cilium essentially
displayed the wild-type localization of GLI2 (Figure 4I).
However, in apparently nonciliated SKDP42.3 cells, we
saw a striking accumulation of GLI2 close to the g-tubulinThe Americanstaining domain, irrespective of whether they had been
stimulated with SAG (Figure 4H, non-SAG-treated cells
shown only). Because GLI2 is not normally localized to
the centrosome, these data raise the possibility that in
WDR60 mutant cells, the mother centriole migrates to
themembrane and initiates basal bodymaturation but fails
to extend an axoneme. Alternatively, a drastically trun-
cated axoneme not detectable by immunofluorescence
analysis may be present in these cells.
Mouse embryonic fibroblasts (MEFs) from embryos null
for Ift144 produce very stunted cilia undetectable by acet-
ylated a-tubulin resulting from the virtual absence of mi-
crotubules within the axoneme.10 We therefore analyzed
ARL13b localization as an independent marker of the
axoneme, along with IFT88, which in Ift144-null MEFs
marks the cilium even in the absence of microtubules.
ARL13b localizes along the axoneme in both control and
ciliated SKDP42.3 cells (Figures 4J and 4L). However, in
those mutant cells with no obvious cilium, ARL13b does
not accumulate with IFT88 at the basal body (Figure 4K),
and there is no evidence of widespread stunted cilia with
either marker, at least at this level of detection. Taken
together, these data suggest that like IFT proteins, GLI2
can be recruited to the basal body in the absence of an
obvious axonemal extension, whereas ARL13b recruit-
ment probably occurs at a later stage in ciliogenesis and/
or by a different mechanism. This is consistent with
Ift144-null MEFs where GLI2 is present in the stunted cilia,
whereas ARL13b is not detectable.10 Furthermore, the fact
that some SKDP42.3 cells are able to form cilia with
apparently normal structural and trafficking properties
suggests that a threshold level of a WDR60-mediated func-
tion may be required in a given cell at a specific time to
allow ciliogenesis.
In summary, by using whole-exome sequencing, initially
in only one individual, we found novel mutations in
WDR60 in an Australian family with SRPS type III and in
a Spanish family with Jeune syndrome. Although both
families share one disease allele, haplotype analysis sug-
gests no shared ancestry. The varying phenotypic severity
caused by mutations in the same gene may be due to
differing effects of the second mutation on protein func-
tion but, consistent with other ciliopathy cases, it may
also reflect differences in the genomic architecture or
epigenetic or other nongenetic factors in each affected in-
dividual. By using fibroblast lines from affected individ-
uals, we have shown a defect in ciliogenesis, possibly
related to failure in IFT-dependent axonemal extension.
Given the connection to IFT in the skeletal ciliopathies
solved to date, future work will explore the function of
WDR60 and its possible role in regulating this specialized
trafficking process.Supplemental Data
Supplemental Data include two figures and four tables and can be
found with this article online at http://www.cell.com/AJHG/.Journal of Human Genetics 93, 515–523, September 5, 2013 521
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